← 返回前沿论文

输卵管组织驻留记忆 T 细胞的转录组分析揭示了一个用于卵巢癌预防的前体免疫监视网络

英文原题:Transcriptomic analysis of tissue-resident memory T cells of the fallopian tube reveals a precursor immune surveillance network for ovarian cancer prevention.

PubMed 2026/07/13(内容时间) Nat Commun Q1 · IF 18.1(JCR 2025)

研究概要

我们发现FT来源的TRML与肿瘤浸润性TRML之间存在显著的克隆和功能重叠(18.4%),超过循环T细胞的重叠程度。

中文摘要

输卵管(FT)日益被认为是高级别浆液性卵巢癌(HGSOC)的起源部位,但其免疫微环境仍知之甚少。在此,我们采用单细胞 RNA 测序和配对 T 细胞受体测序,对来自患者匹配的非癌性 FT、转移性肿瘤和外周血的组织驻留记忆样 T 细胞(TRML)进行了分析。我们鉴定出 FT 来源与肿瘤浸润 TRML 之间存在显著的克隆和功能重叠(18.4%),超过循环 T 细胞。共享克隆型优先富集于耗竭 CD8+ 亚群中,包括一个此前未表征的 SIK3-high 亚群,与表观遗传可塑性和代谢适应相关。在功能上,FT 来源的 TRML 可识别自体肿瘤抗原,在类器官共培养实验中表现出强烈的干扰素-γ(IFN-γ)反应和 CD137 上调,支持其在早期免疫监视中的作用。值得注意的是,FT TRML 的耗竭程度低于肿瘤对应细胞,提示其治疗潜力。这些发现揭示了 FT 中存在一个前体免疫监视网络,并支持利用 FT 驻留 T 细胞进行癌症免疫治疗和预防。

展开英文摘要原文

The fallopian tube (FT) is increasingly recognized as the origin of high-grade serous ovarian cancer (HGSOC), yet its immune landscape remains poorly understood. Here, we employ single-cell RNA sequencing and paired T-cell receptor sequencing to profile tissue-resident memory-like T cells (TRML) from patient-derived matched non-cancerous FT, metastatic tumors, and peripheral blood. We identify substantial clonal and functional overlap (18.4%) between FT-derived and tumor-infiltrating TRMLs, exceeding that of circulating T cells. Shared clonotypes are preferentially enriched in exhausted CD8+ subsets, including a previously uncharacterized SIK3-high subset linked to epigenetic plasticity and metabolic adaptation. Functionally, FT-derived TRMLs recognize autologous tumor antigens, showing strong interferon-γ (IFN-γ) responses and CD137 upregulation in organoid coculture assays, supporting a role in early immune surveillance. Notably, FT TRMLs exhibit lower exhaustion than tumor counterparts, suggesting therapeutic potential. These findings reveal a precursor immune surveillance network in the FT and support leveraging FT-resident T cells for cancer immunotherapy and prevention.

论文信息

作者
Wang L、Roskams-Hieter B、Hussain N、Nulsen J、Aggarwal A、Sallam M、Wang L、Rai L
第一作者单位
Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.United Kingdom
通讯作者单位
Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. ahmed.ahmed@wrh.ox.ac.uk.United Kingdom
期刊
Nature communications2026 Jul 13
原文标识
PubMed 42443174 · DOI 10.1038/s41467-026-74599-4